Skip to content

About the Summit

The PARP & DDR Inhibitors Summit 2020 gathers the VPs, Heads and Directors of Translational Oncology, Target Discovery, and Early Drug Development. This meeting is the perfect opportunity to gain cutting-edge insights from industry leaders on PARP inhibitor development, creating best-in-class therapeutics, over-riding resistance and identifying novel synthetic lethal pathways to exploit cancer survival mechanisms.

Step out of the office and into a meeting tailored to your niche. Round table talks, panel discussion and networking provide a unique opportunity for open conversation with industry leaders to accelerate your DDR success.

Gain Unique Insights into the Key Issues Facing the Industry

PARP DDR Icon 1

Leverage Therapeutic Combinations

PARP DDR Icon 2

Identify Patient Populations

PARP DDR Icon 3

Expand Drug Efficacy to Wider Indications

PARP DDR Icon 4

Create Pathways to Over-Ride Resistance

PARP DDR Icon 5

Analyze the Emerging DDR Landscape